29 December 2016

VERONA PHARMA PLC - Issue of Equity

PR Newswire

Read more

23 November 2016

VERONA PHARMA PLC - Registered Initial Public Offering in the US

PR Newswire

Read more

23 November 2016

Verona Pharma plans to conduct registered Initial Public Offering in the U.S.

Read more

26 October 2016

VERONA PHARMA PLC - Second Venture and Innovation Award from the CF Trust

PR Newswire

Read more

26 October 2016

Verona Pharma receives second Venture and Innovation Award from the Cystic Fibrosis Trust

Read more

20 October 2016

Exercise of options

                                              …

Read more

19 October 2016

VERONA PHARMA PLC - Notice of Cancellation of Trading on Xetra

PR Newswire

Read more

28 September 2016

Exercise of options

                                              …

Read more

26 September 2016

VERONA PHARMA PLC - Appointment of CFO

PR Newswire

Read more

13 September 2016

VERONA PHARMA PLC - Half-year Report

PR Newswire

Read more

Targeting unmet needs

384m people worldwide suffer from COPD and 37 years is the median life expectancy of CF patients

Read more about COPD and CF in the unmet needs section of this website

Go

Basic & Clinical Pharmacology & Toxicology

Peer-reviewed publication on dual PDE3/4 inhibitors as novel treatments for COPD

The Lancet Respiratory Medicine

Peer-reviewed paper in the Lancet's highly-respected medication journal

Close

Verona Pharma plc
3 More London Riverside, London SE1 2RE
T: +44 (0)203 283 4200

Linkedin     Email Us